help to make World Diabetes Day a global success by providing valuable support for the development of campaign resources and ...
A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...
Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...
MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...
Privately-held Flare Therapeutics, a US biotech targeting transcription factors to discover precision medicines for oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback